PIRATES: Image-guided Hyper-fractioned Dose-escalation With Proton Therapy for Head and Neck Cancer

In this study the safety \& feasibility of image-guided mid-treatment hyper-fractioned dose-escalation with proton therapy will be assessed for the treatment of locally advanced HPV-negative squamous cell oropharyngeal cancer

Trial Details

NCT ID
NCT06446713
Phase
PHASE1
Sponsor
University Medical Center Groningen
Status
RECRUITING
Cancer Type
Head and Neck Cancer
Interventions
  • Image guided hybrid hyper-fractioned dose escalation with proton therapy
Locations (sample)
  • Groningen, Netherlands|53.21917,6.56667

Key Eligibility Criteria

  • In order to be eligible to participate in this study, a subject must meet all of the following criteria:
  • Biopsy proven diagnosis of squamous cell carcinoma originating in the oropharynx.
  • Routine staging procedures, including CT of the head and neck region and chest, head and neck FDG-PET/CT and MRI (treatment planning allowed), and …
  • Negative for p16

For full eligibility, visit ClinicalTrials.gov.

Check If You May Be Eligible

Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.

Find Head and Neck Cancer Trials on Trialify →